LDHA and colorectal carcinoma: More importantly, targeted lactate metabolism reprogramming has the potential to be a potential pathway to reverse chemoresistance and increase treatment sensitivity, and METTL3/LDHA axis-induced glucose metabolism may be a potential therapeutic target for CRC cells to overcome 5-FU resistance (112).